---
title: "Docosanol - Herpes Labialis"
sidebar: mydoc_sidebar
permalink: db00632-mesh-d006560-1.html
toc: false 
---


Path ID: `DB00632_MESH_D006560_1`
{% include image.html url="images/db00632-mesh-d006560-1.png" file="db00632-mesh-d006560-1.png" alt="db00632-mesh-d006560-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C529236 | Docosanol | Drug |
| UniProt:P03200 | Envelope glycoprotein GP350 (Epstein-Barr virus) | Protein |
| GO:0016032 | Viral process | BiologicalProcess |
| NCBITaxon:10298 | Human alphaherpesvirus 1 | OrganismTaxon |
| MESH:D006560 | Herpes labialis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Docosanol | DECREASES ACTIVITY OF | Envelope Glycoprotein Gp350 (Epstein-Barr Virus) |
| Envelope Glycoprotein Gp350 (Epstein-Barr Virus) | PARTICIPATES IN | Viral Process |
| Viral Process | IN TAXON | Human Alphaherpesvirus 1 |
| Human Alphaherpesvirus 1 | CAUSES | Herpes Labialis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00632](https://go.drugbank.com/drugs/DB00632)
